Relationship between hypercholesterolemia, lipid-lowering therapy and coronary flow velocity reserve evaluated by stress transesophageal echocardiography in patients with a negative coronary angiogram

被引:8
作者
Nemes, A [1 ]
Neu, K
Forster, T
Gruber, N
Csanády, M
机构
[1] Univ Szeged, Fac Med, Albert Szent Gyorgyi Med & Pharmaceut Ctr, Dept Med 2, Szeged, Hungary
[2] Univ Szeged, Fac Med, Albert Szent Gyorgyi Med & Pharmaceut Ctr, Ctr Cardiol, Szeged, Hungary
来源
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES | 2004年 / 21卷 / 01期
关键词
cholesterol level; coronary flow; ischemic heart disease; transesophageal echocardiography;
D O I
10.1111/j.0742-2822.2004.03009.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The coronary flow velocity reserve (CFR) depends not only on vascular, extravascular, and rheological factors, but also on metabolic factors, such as the cholesterol level. The aim of the present study was to examine the relationship between hypercholesterolemia, the application or not of 6 months lipid-lowering therapy, and the CFR evaluated by pharmacological stress transesophageal echocardiography (PSTEE) inpatients without major coronary artery disease. Patients and Methods: Sixty-nine patients with a negative coronary angiogram were enrolled in the study. Thirty-two of these patients received lipid-lowering therapy, while 37 did not. The CFR was measured by means of dipyridamole PSTEE in all cases, and was calculated as the ratio of posthyperemic to basal peak diastolic flow velocities. Results: Of the 32 patients who received lipid-lowering medication, the cholesterol level was normal in 16 cases (CFR 2.47 +/- 0.88), while it remained increased in 16 patients (CFR 2.18 +/- 0.67) at the time of the examination. The 7 patients who did not participate in lipid-lowering therapy and who exhibited an increased cholesterol level were also examined (CFR 2.03 +/- 0.88). In 30 patients with normal cholesterol level, who did not receive any lipid-lowering medication, the CFR was significantly increased compared to cases with an increased level (CFR 2.65 +/- 0.79). Conclusion: It may be stated that in the patients who did not receive lipid-lowering medication and who displayed normocholesterolemia, the CFR evaluated by means of PSTEE was significantly higher than in the patients who had an increased cholesterol level.
引用
收藏
页码:37 / 41
页数:5
相关论文
共 12 条
[1]   Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis [J].
Baller, D ;
Notohamiprodjo, G ;
Gleichmann, U ;
Holzinger, J ;
Weise, R ;
Lehmann, J .
CIRCULATION, 1999, 99 (22) :2871-2875
[2]  
Baller D., 1998, Zeitschrift fuer Kardiologie, V87, P136
[3]   Current concepts of coronary flow reserve for clinical decision making during cardiac catheterisation [J].
Baumgart, D ;
Haude, M ;
Liu, FQ ;
Ge, JB ;
Goerge, G ;
Erbel, R .
AMERICAN HEART JOURNAL, 1998, 136 (01) :136-149
[4]   Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin [J].
Guethlin, M ;
Kasel, AM ;
Coppenrath, K ;
Ziegler, S ;
Delius, W ;
Schwaiger, M .
CIRCULATION, 1999, 99 (04) :475-481
[5]   TRANSESOPHAGEAL DOPPLER ECHOCARDIOGRAPHY EVALUATION OF CORONARY BLOOD-FLOW VELOCITY IN BASE-LINE CONDITIONS AND DURING DIPYRIDAMOLE-INDUCED CORONARY VASODILATION [J].
ILICETO, S ;
MARANGELLI, V ;
MEMMOLA, C ;
RIZZON, P .
CIRCULATION, 1991, 83 (01) :61-69
[6]   Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia [J].
Kaufmann, PA ;
Gnecchi-Ruscone, T ;
Schäfers, KP ;
Lüscher, TF ;
Camici, PG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (01) :103-109
[7]   Improvement of coronary vasodilatation capacity through single LDL apheresis [J].
Mellwig, KP ;
Baller, D ;
Gleichmann, U ;
Moll, D ;
Betker, S ;
Weise, R ;
Notohamiprodjo, G .
ATHEROSCLEROSIS, 1998, 139 (01) :173-178
[8]   Coronary flow reserve is impaired in young men with familial hypercholesterolemia [J].
Pitkanen, OP ;
Raitakari, OT ;
Niinikoski, H ;
Nuutila, P ;
Iida, H ;
VoipioPulkki, LM ;
Harkonen, R ;
Wegelius, U ;
Ronnemaa, T ;
Viikari, J ;
Knuuti, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (07) :1705-1711
[9]   Coronary flow reserve in young men with familial combined hyperlipidemia [J].
Pitkänen, OP ;
Nuutila, P ;
Raitakari, OT ;
Porkka, K ;
Iida, H ;
Nuotio, I ;
Rönnemaa, T ;
Viikari, J ;
Taskinen, MR ;
Ehnholm, C ;
Knuuti, J .
CIRCULATION, 1999, 99 (13) :1678-1684
[10]  
STRAUER BE, 1992, J CARDIOVASC PHAR S5, V19, P67